Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow
to the tumor.
PURPOSE: Phase II trial to study the effectiveness of carboxyamidotriazole in treating
patients who have advanced kidney cancer that has not responded to biological therapy.